Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-centre, Open-label, First-in-man Study With Mucopad HA Used in Adult Patients Suffered From Oral Mucositis After Radiotherapy

NCT06276270 is registered in ClinicalTrials.gov with Contipro Pharma a.s. as lead sponsor.

NCT NCT06276270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06276270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-centre, Open-label, First-in-man Study With Mucopad HA Used in Adult Patients Suffered From Oral Mucositis After Radiotherapy
Lead sponsor
Contipro Pharma a.s.
Phase
Not applicable
Overall status
Completed
Start date
December 12, 2023
Completion date
November 30, 2024
Enrollment
50 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

oral mucositis